Howard Hughes Medical Institute’s Intel INTC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$7.98M Hold
57,142
1.79% 13
2026
Q1
$2.52M Buy
57,142
+56,177
+5,821% +$2.57M 0.61% 23
2025
Q4
$35.6K Buy
965
+26
+3% +$982 0.02% 67
2025
Q3
$31.5K Buy
939
+5
+0.5% +$121 0.02% 74
2025
Q2
$20.9K Buy
+934
New +$19.4K 0.01% 107
2022
Q4
Sell
-114,000
Closed -$2.94M 26
2022
Q3
$2.94M Buy
+114,000
New +$3.89M 0.84% 37

Other funds holding INTC

Howard Hughes Medical Institute's INTC Position: Q2 2026 in Review

Howard Hughes Medical Institute held its Intel (INTC) position steady in Q2 2026 at 57,142 shares worth $7.98M. The position accounts for 1.79% of the portfolio, ranked #13.

Howard Hughes Medical Institute first reported a position in INTC in Q3 2022 and has held it in 6 quarters since. 3,554 funds tracked by Wall St. Rank hold INTC as of Q2 2026.

  • Howard Hughes Medical Institute held 57,142 shares of Intel worth $7.98M as of Q2 2026.
  • Howard Hughes Medical Institute left its Intel share count unchanged in Q2 2026.
  • Intel made up 1.79% of Howard Hughes Medical Institute's portfolio in Q2 2026, its #13 holding.
  • Howard Hughes Medical Institute first reported a position in Intel in Q3 2022 and has held it in 6 quarters since.
  • 3,554 funds tracked by Wall St. Rank held Intel as of Q2 2026.

Based on Howard Hughes Medical Institute's 13F filing for Q2 2026, filed 14 Aug 2026.